Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
Monthly archive
June 2010
News
Is Shire the Next Genzyme, Minus the Headaches?
Minyanville
Fabrazyme
Fabry's disease
Genzyme
Replagal
Shire
»
6 comments
News
Report: Exelixis' Scangos named Biogen CEO
Bizjournals.com
Biogen Idec
Exelixis
George Scangos
Pharma CEOs
»
3 comments
News
Off the Hook: Why Drug Prosecutions Are Targeting Middle Managers and Letting Bosses Slide
BNET Pharma
fraud
lawsuits
»
1 comment
News
GlaxoSmithKline licenses Futura pain drug
Bizjournals.com
Futura
GSK
liscensing
»
1 comment
News
Genzyme warns of drug supply disruptions
Reuters
Cerezyme
drug manufacturing
Fabrazyme
Genzyme
shortages
»
10 comments
News
Merck KGaA expects MS pill to lift drugs margin
Reuters
cladribine
Gilenia
Merck KGaA
Merck Serono
MS
multiple sclerosis
»
5 comments
News
Diabetes Drug Development Pops and Drops
Motley Fool
Afrezza
Amylin
Avandia
Contrave
diabetes
Eli Lilly
GSK
JNJ
MannKind
Merck
Novo Nordisk
Orexigen
»
8 comments
News
We Hate Your Financial Influence but we Like Your Money
Pharmareform
CME
healthcare reform
Massachusetts
Pfizer
physicial payments
physicians
»
7 comments
News
The Cholesterol Debate And Journal Disclosures
Pharmalot
cholesterol
Crestor
CRP
JUPITER
Pfizer
»
1 comment
News
Backgrounders On Today's Biotech Deals
Forbes
Celgene
companies
M&A
Sanofi
TargeGen
»
3 comments
1
2
3
4
5
6
7
8
9
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT